DE60205870D1 - Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil - Google Patents

Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil

Info

Publication number: DE60205870D1
Authority: DE; Germany
Prior art keywords: pharmaceutical composition; oral pharmaceutical; proxetil; cefpodoxim; cefpodoxim proxetil
Prior art date: 2001-02-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60205870T

Other languages

English (en)

Other versions

DE60205870T2 (de

Inventor

Mukta Malhotra

Rajeev Shankar Mathur

Rajiv Malik

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ranbaxy Laboratories Ltd

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-27

Publication date

2005-10-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60205870(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-02-27 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2005-10-06 Application granted granted Critical

2005-10-06 Publication of DE60205870D1 publication Critical patent/DE60205870D1/de

2006-06-29 Publication of DE60205870T2 publication Critical patent/DE60205870T2/de

2022-02-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

LTINZAODLRIQIX-ZFEISNGRSA-N 1-propan-2-yloxycarbonyloxyethyl (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical group N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N\OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-ZFEISNGRSA-N 0.000 title 1
239000008203 oral pharmaceutical composition Substances 0.000 title 1
LTINZAODLRIQIX-FBXRGJNPSA-N cefpodoxime proxetil Chemical group N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N/OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-FBXRGJNPSA-N 0.000 abstract 1
229960004797 cefpodoxime proxetil Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60205870T 2001-02-27 2002-02-27 Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil Expired - Fee Related DE60205870T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN190DE2001		2001-02-27
INDE00001900		2001-02-27
PCT/IB2002/000602 WO2002067943A1 (en)	2001-02-27	2002-02-27	Oral pharmaceutical composition of cefpodoxime proxetil

Publications (2)

Publication Number	Publication Date
DE60205870D1 true DE60205870D1 (de)	2005-10-06
DE60205870T2 DE60205870T2 (de)	2006-06-29

Family

ID=11097036

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60205870T Expired - Fee Related DE60205870T2 (de)	2001-02-27	2002-02-27	Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil

Country Status (14)

Country	Link
EP (1)	EP1365764B1 (de)
JP (1)	JP2004522782A (de)
KR (1)	KR20030087009A (de)
CN (1)	CN1505515A (de)
AT (1)	ATE303149T1 (de)
AU (1)	AU2002237462B2 (de)
BR (1)	BR0207640A (de)
DE (1)	DE60205870T2 (de)
EA (1)	EA006974B1 (de)
ES (1)	ES2248521T3 (de)
MX (1)	MXPA03007678A (de)
NZ (1)	NZ527867A (de)
OA (1)	OA12687A (de)
WO (1)	WO2002067943A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6766376B2 (en)	2000-09-12	2004-07-20	Sn Acquisition, L.L.C	Streaming media buffering system
ATE415150T1 (de) *	2002-08-16	2008-12-15	Orchid Chemicals & Pharm Ltd	Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum
AU2002321743A1 (en) *	2002-08-19	2004-03-03	Orchid Health Care	Sustained release pharmaceutical composition of a cephalosporin antibiotic
WO2004105728A2 (en) *	2003-05-27	2004-12-09	Ranbaxy Laboratories Limited	Solid dispersions of cefpodoxime proxetil and processes for their preparation
JP2008540403A (ja) *	2005-05-05	2008-11-20	ルピン・リミテッド	セファロスポリンの安定化経口用医薬組成物
JP2008540691A (ja) *	2005-05-16	2008-11-20	エラン・ファルマ・インターナショナル・リミテッド	セファロスポリンを含むナノ粒子および放出制御組成物
US8900637B2 (en) *	2005-12-02	2014-12-02	Lupin Limited	Stable taste masked formulations of cephalosporins
WO2008057058A1 (en) *	2006-11-10	2008-05-15	Nobel Ilac Sanayii Ve Ticaret As	Oral pharmaceutical compositions
CN101278914B (zh) *	2008-01-02	2010-06-02	海南三叶美好制药有限公司	头孢泊肟酯干混悬剂组合物及其制备方法
TR201001417A1 (tr) *	2010-02-25	2011-09-21	Sanovel İlaç San. Ve Ti̇c. A. Ş.	Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu
TR201002878A2 (tr)	2010-04-13	2011-10-21	Bi̇lgi̇ç Mahmut	Sefpodoksim proksetil içeren farmasötik bileşimler.
WO2011152805A2 (en) *	2010-06-03	2011-12-08	Mahmut Bilgic	Pharmaceutical composition comprising cefpodoxime proxetil and clavulanic acid
TR201007107A1 (tr) *	2010-08-25	2012-03-21	B�Lg�� Mahmut	Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201007106A1 (tr) *	2010-08-25	2012-03-21	Bi̇lgi̇ç Mahmut	Sefpodoksim proksetil formülasyonları.
TR201009168A2 (tr) *	2010-11-05	2012-05-21	Bi̇lgi̇ç Mahmut	Suda dağılan sefpodoksim proksetil formülasyonları.
EP2647648B1 (de) *	2010-12-03	2017-08-09	Nippon Soda Co., Ltd.	Feste Darreichungsform enthaltend eine niedrigviskose HYDROXYALKYLCELLULOSE
WO2013145750A1 (ja) *	2012-03-29	2013-10-03	杏林製薬株式会社	カプセル製剤
ES2717282T3 (es)	2012-07-27	2019-06-20	Redhill Biopharma Ltd	Formulaciones y métodos para fabricar formulaciones para su uso en la evacuación colónica
CN103142506B (zh) *	2013-04-03	2015-02-25	天津医药集团津康制药有限公司	一种头孢泊肟酯颗粒剂及其制备方法
US9603804B2 (en)	2013-04-25	2017-03-28	Kyorin Pharmaceutical Co., Ltd.	Solid pharmaceutical composition
JP5700740B1 (ja)	2013-04-25	2015-04-15	杏林製薬株式会社	固形医薬組成物
KR101509168B1 (ko) *	2013-06-10	2015-04-06	한국화학연구원	세팔로스포린 항생제의 서방형 제제 및 이를 포함하는 서방형 약제학적 조성물
CN103301075B (zh) *	2013-06-28	2015-11-18	山东罗欣药业集团股份有限公司	一种头孢克肟组合物混悬颗粒剂及其制备方法
JP6292788B2 (ja) *	2013-07-30	2018-03-14	ライオン株式会社	錠剤及び錠剤の製造方法
JP2016204260A (ja) *	2013-10-04	2016-12-08	日本曹達株式会社	錠剤の製造方法
US10154993B2 (en)	2014-10-23	2018-12-18	Kyorin Pharmaceutical Co., Ltd.	Solid pharmaceutical composition
CN104771368B (zh) *	2015-04-08	2017-12-22	石家庄四药有限公司	头孢泊肟酯速释制剂及其制备方法
CN113456599A (zh) *	2020-03-30	2021-10-01	洛阳惠中兽药有限公司	一种头孢泊肟酯片的制备方法及其制备的头孢泊肟酯片
CN113952313A (zh) *	2021-08-26	2022-01-21	宁夏医科大学	一种头孢呋辛酯胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4486425A (en) *	1980-09-30	1984-12-04	Sankyo Company Limited	7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
US5929086A (en) *	1996-05-10	1999-07-27	Pharmacia & Upjohn Company	Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
AT500063A1 (de) *	1999-11-23	2005-10-15	Sandoz Ag	Beschichtete tablettenkerne
MXPA02012670A (es) *	2000-06-21	2003-10-06	Cubist Pharm Inc	Composiciones y metodos para mejorar la absorcion oral de agentes anti-microbianos.

2002
- 2002-02-27 ES ES02703777T patent/ES2248521T3/es not_active Expired - Lifetime
- 2002-02-27 BR BR0207640-3A patent/BR0207640A/pt not_active Application Discontinuation
- 2002-02-27 KR KR10-2003-7011273A patent/KR20030087009A/ko not_active Withdrawn
- 2002-02-27 MX MXPA03007678A patent/MXPA03007678A/es unknown
- 2002-02-27 OA OA1200300220A patent/OA12687A/en unknown
- 2002-02-27 AT AT02703777T patent/ATE303149T1/de not_active IP Right Cessation
- 2002-02-27 EA EA200300937A patent/EA006974B1/ru not_active IP Right Cessation
- 2002-02-27 AU AU2002237462A patent/AU2002237462B2/en not_active Ceased
- 2002-02-27 EP EP02703777A patent/EP1365764B1/de not_active Expired - Lifetime
- 2002-02-27 WO PCT/IB2002/000602 patent/WO2002067943A1/en not_active Ceased
- 2002-02-27 NZ NZ52786702A patent/NZ527867A/xx unknown
- 2002-02-27 CN CNA028089766A patent/CN1505515A/zh active Pending
- 2002-02-27 JP JP2002567310A patent/JP2004522782A/ja active Pending
- 2002-02-27 DE DE60205870T patent/DE60205870T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60205870T2 (de)	2006-06-29
ATE303149T1 (de)	2005-09-15
MXPA03007678A (es)	2004-03-16
JP2004522782A (ja)	2004-07-29
EA006974B1 (ru)	2006-06-30
ES2248521T3 (es)	2006-03-16
NZ527867A (en)	2004-12-24
CN1505515A (zh)	2004-06-16
EA200300937A1 (ru)	2004-04-29
OA12687A (en)	2006-06-21
WO2002067943A1 (en)	2002-09-06
EP1365764B1 (de)	2005-08-31
BR0207640A (pt)	2004-07-27
EP1365764A4 (de)	2004-08-11
KR20030087009A (ko)	2003-11-12
EP1365764A1 (de)	2003-12-03
AU2002237462B2 (en)	2006-05-18

Publication	Publication Date	Title
ATE303149T1 (de)	2005-09-15	Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CO5590918A2 (es)	2005-12-30	Formulaciones
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
PT1379520E (pt)	2006-08-31	Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
DK1300398T3 (da)	2006-07-17	Propan-1,3-dionderivat
CY1108067T1 (el)	2014-02-12	Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
NO20034660L (no)	2003-12-17	Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater
HN1999000066A (es)	1999-09-29	Formulaciones farmaceuticas
PL375874A1 (pl)	2005-12-12	Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
CY1110258T1 (el)	2015-01-14	Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
CY1105387T1 (el)	2010-04-28	Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
ATE252377T1 (de)	2003-11-15	Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
SE9901077D0 (sv)	1999-03-23	Novel use
NO20034556L (no)	2003-12-10	Imidazotriazinon-holdige sammensetninger for nasal administrering
CY1105039T1 (el)	2010-03-03	ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ
TNSN06012A1 (en)	2007-10-03	Emulsifying systems containing azetidine derivatives
NO20064808L (no)	2006-12-15	Orale matrixformuleringer med licarbazepin
CY1106712T1 (el)	2012-05-23	Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
EA200601015A1 (ru)	2006-10-27	Пероральные композиции дезоксипеганина и их применение
MY142077A (en)	2010-08-30	Semi-solid systems containing azetidine derivatives
AR023056A1 (es)	2002-09-04	Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
EE05380B1 (et)	2011-02-15	FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid
DE60102704D1 (de)	2004-05-13	Trioxepan verbindungen

Legal Events

Date	Code	Title	Description
2006-08-17	8363	Opposition against the patent
2007-12-13	8339	Ceased/non-payment of the annual fee